OncoGenex and Sarah Cannon Announce Completion of Patient Enrollment in the Spruceâ¢ Clinical Trial Evaluating Apatorsen in Combination with Carboplatin and Pemetrexed in Patients with Advanced Non-Squamous Non-Small Cell L